Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:BIB NASDAQ:IBBQ NYSEARCA:RXL NYSEARCA:SURI On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBIBProShares Ultra Nasdaq Biotechnology$97.99-1.1%$90.90$49.24▼$110.25$82.31M1.1911,261 shs3,483 shsIBBQInvesco Nasdaq Biotechnology ETF$32.28-0.6%$30.97$22.04▼$34.22$74.57M0.629,386 shs17,908 shsRXLProShares Ultra Health Care$55.18+1.5%$50.53$36.23▼$57.41$84.43M1.1310,040 shs7,425 shsSURISimplify Propel Opportunities ETF$17.94-1.2%$17.61$14.70▼$18.50$76.96M1.066,689 shs1,500 shsThe Infrastructure's Backbone: 10 Stocks Powering the AI BuildoutThe AI boom extends far beyond the biggest tech names. Discover 10 companies supplying the memory, storage, networking, semiconductor manufacturing, and power infrastructure that make AI possible. Learn where the next wave of AI investment opportunities may emerge—and the key risks investors should watch as the global AI buildout accelerates.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBIBProShares Ultra Nasdaq Biotechnology-1.07%-2.09%+6.15%+18.47%+84.78%IBBQInvesco Nasdaq Biotechnology ETF-0.55%-1.04%+3.43%+10.02%+41.45%RXLProShares Ultra Health Care+1.45%+1.70%+11.47%+25.15%+33.74%SURISimplify Propel Opportunities ETF-1.16%+0.34%+4.24%+7.43%+14.56%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBIBProShares Ultra Nasdaq Biotechnology$97.99-1.1%$90.90$49.24▼$110.25$82.31M1.1911,261 shs3,483 shsIBBQInvesco Nasdaq Biotechnology ETF$32.28-0.6%$30.97$22.04▼$34.22$74.57M0.629,386 shs17,908 shsRXLProShares Ultra Health Care$55.18+1.5%$50.53$36.23▼$57.41$84.43M1.1310,040 shs7,425 shsSURISimplify Propel Opportunities ETF$17.94-1.2%$17.61$14.70▼$18.50$76.96M1.066,689 shs1,500 shsThe Infrastructure's Backbone: 10 Stocks Powering the AI BuildoutThe AI boom extends far beyond the biggest tech names. Discover 10 companies supplying the memory, storage, networking, semiconductor manufacturing, and power infrastructure that make AI possible. Learn where the next wave of AI investment opportunities may emerge—and the key risks investors should watch as the global AI buildout accelerates.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBIBProShares Ultra Nasdaq Biotechnology-1.07%-2.09%+6.15%+18.47%+84.78%IBBQInvesco Nasdaq Biotechnology ETF-0.55%-1.04%+3.43%+10.02%+41.45%RXLProShares Ultra Health Care+1.45%+1.70%+11.47%+25.15%+33.74%SURISimplify Propel Opportunities ETF-1.16%+0.34%+4.24%+7.43%+14.56%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceBIBProShares Ultra Nasdaq Biotechnology 2.71Moderate Buy$97.99N/AIBBQInvesco Nasdaq Biotechnology ETF 2.71Moderate Buy$32.28N/ARXLProShares Ultra Health Care 2.78Moderate Buy$55.18N/ASURISimplify Propel Opportunities ETF 2.59Moderate Buy$17.94N/ACurrent Analyst Ratings BreakdownCompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookBIBProShares Ultra Nasdaq BiotechnologyN/AN/AN/AN/AN/AN/AIBBQInvesco Nasdaq Biotechnology ETFN/AN/AN/AN/AN/AN/ARXLProShares Ultra Health CareN/AN/AN/AN/AN/AN/ASURISimplify Propel Opportunities ETFN/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateBIBProShares Ultra Nasdaq BiotechnologyN/AN/A20.68N/AN/AN/AN/AN/AN/AIBBQInvesco Nasdaq Biotechnology ETFN/AN/A17.03N/AN/AN/AN/AN/AN/ARXLProShares Ultra Health CareN/AN/A24.86N/AN/AN/AN/AN/AN/ASURISimplify Propel Opportunities ETFN/AN/AN/AN/AN/AN/AN/AN/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthBIBProShares Ultra Nasdaq Biotechnology$0.320.33%N/AN/AN/AIBBQInvesco Nasdaq Biotechnology ETF$0.250.77%N/AN/AN/ARXLProShares Ultra Health Care$0.701.27%N/AN/AN/ASURISimplify Propel Opportunities ETF$2.7215.16%N/AN/AN/ALatest SURI, RXL, IBBQ, and BIB DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date6/22/2026IBBQInvesco Nasdaq Biotechnology ETFQuarterly$0.03426/22/20266/22/20266/26/2026(Data available from 1/1/2013 forward)Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipBIBProShares Ultra Nasdaq BiotechnologyN/AIBBQInvesco Nasdaq Biotechnology ETFN/ARXLProShares Ultra Health CareN/ASURISimplify Propel Opportunities ETFN/AInsider OwnershipCompanyInsider OwnershipBIBProShares Ultra Nasdaq BiotechnologyN/AIBBQInvesco Nasdaq Biotechnology ETFN/ARXLProShares Ultra Health CareN/ASURISimplify Propel Opportunities ETFN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableBIBProShares Ultra Nasdaq BiotechnologyN/A840,000N/AOptionableIBBQInvesco Nasdaq Biotechnology ETFN/A2.31 millionN/AOptionableRXLProShares Ultra Health CareN/A1.53 millionN/ANot OptionableSURISimplify Propel Opportunities ETFN/A4.29 millionN/ANot OptionableSURI, IBBQ, RXL, and BIB HeadlinesRecent News About These CompaniesSimplify Propel Opportunities ETF declares $0.68 dividendJune 30, 2025 | seekingalpha.comSimplify Propel Opportunities ETF declares quarterly distribution of $0.6800March 28, 2025 | seekingalpha.comSimplify Provides Estimated Capital Gain Distribution Information for 2024November 27, 2024 | businesswire.com(SURI) Trading ReportNovember 7, 2024 | news.stocktradersdaily.comNSimplify Propel Opportunities ETF (SURI)October 20, 2024 | investing.comSURI Simplify Propel Opportunities ETFOctober 18, 2024 | seekingalpha.com(SURI) On The My Stocks PageOctober 16, 2024 | news.stocktradersdaily.comNBest-Performing ETFs of Last WeekSeptember 24, 2024 | zacks.comNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All HeadlinesSK Hynix’s Nasdaq Listing Could Reset the AI Memory TradeBy Thomas Hughes | July 7, 20265 Tech Stocks to Buy on the July PullbackBy Thomas Hughes | June 29, 2026Rocket Lab’s Stock Drop Comes With a Bullish TwistBy Ryan Hasson | July 10, 2026Visa’s Open USD Push Puts Circle’s Stablecoin Moat Under PressureBy Jeffrey Neal Johnson | July 5, 2026Meta’s AI Compute Push Could Turn Its Massive CapEx Bill Into a Competitive WeaponBy Jeffrey Neal Johnson | July 2, 2026SURI, IBBQ, RXL, and BIB Company DescriptionsProShares Ultra Nasdaq Biotechnology NASDAQ:BIB$97.99 -1.05 (-1.06%) Closing price 07/24/2026 03:59 PM EasternExtended Trading$97.88 -0.11 (-0.12%) As of 07/24/2026 07:34 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.ProShares Ultra Nasdaq Biotechnology (the Fund) seeks daily investment results, before fees and expenses, that correspond to twice (200%) the daily performance of the Index. The return of the Fund for a period longer than a single trading day will be the result of each day's returns compounded over the period, which will very likely differ from the inverse of the return of the Dow Jones United States Basic Materials Index (the Index) for that period. The Fund does not seek to achieve its stated investment objective over a period of time greater than one day. The Fund invests in derivatives that have similar daily performance characteristics as the inverse of the daily return of the Index. The Fund invests in financial instruments whose value is derived from the value of an underlying asset, interest rate or index. ProShare Advisors LLC is the investment advisor of the Fund.Invesco Nasdaq Biotechnology ETF NASDAQ:IBBQ$32.28 -0.18 (-0.55%) As of 07/24/2026 04:00 PM EasternThe Invesco Nasdaq Biotechnology ETF (IBBQ) is an exchange-traded fund that is based on the NASDAQ / Biotechnology index, a modified market-cap-weighted index of US biotechnology and pharmaceutical companies listed on the NASDAQ. IBBQ was launched on Jun 11, 2021 and is managed by Invesco.ProShares Ultra Health Care NYSEARCA:RXL$55.18 +0.79 (+1.45%) Closing price 07/24/2026 04:10 PM EasternExtended Trading$55.19 +0.01 (+0.02%) As of 07/24/2026 07:34 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.ProShares Ultra Health Care (the Fund) seeks daily investment results that correspond to twice (200%) the daily performance of the Dow Jones U.S. Health Care Index (the Index). The Fund intends to invest at least 80% of its net assets, including any borrowings for investment purposes, under normal circumstances, to equity securities contained in the Index and/or financial instruments that, in combination, have similar economic characteristics. The Fund also intends to invest assets not invested in financial instruments, in debt instruments and/or money market instruments. The Fund intends to concentrate its investments in a particular industry or group of industries to approximately the same extent as the Index is so concentrated. ProShare Advisors LLC serves as the investment advisor to the Fund.Simplify Propel Opportunities ETF NYSEARCA:SURI$17.94 -0.21 (-1.16%) As of 07/24/2026 04:10 PM EasternThe Simplify Propel Opportunities ETF (SURI) is an exchange-traded fund that mostly invests in target outcome asset allocation. The fund employs an actively managed, multi-asset strategy that focuses on equity and debt securities of companies in the healthcare sector. The fund selects securities believed to be attractive investment opportunities SURI was launched on Feb 7, 2023 and is managed by Simplify. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 07/20- 07/24 Telecom Earnings Reveal a Sector That Finally Looks Healthier AMD and Cerbras Create A New Blueprint For Hardware Intel Earnings Reveal Whether the Chip Selloff Created a Buy CrowdStrike’s Cerebras Deal Puts Its AI Security Strategy to the Test Defense Earnings Show Readiness Now and Modernization Ahead Freeport McMoRan Post-Earnings: Why Good Enough May Finally Be Good Enough Tesla Just Delivered Record Sales—So Why Did the Stock Sell Off? Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
